Study to Evaluate the Effects of Fasinumab on Peripheral Nerve Function in Patients With Pain Due to Osteoarthritis of the Hip or Knee

PHASE2CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

October 15, 2018

Primary Completion Date

January 30, 2020

Study Completion Date

January 7, 2021

Conditions
Osteoarthritis, KneeOsteoarthritis, Hip
Interventions
DRUG

Fasinumab

Subcutaneous (SC) every four weeks (Q4W)

OTHER

Placebo

Subcutaneous (SC) every four weeks (Q4W)

Trial Locations (47)

10530

Regeneron Study Site, Hartsdale

30189

Regeneron Study Site, Woodstock

32256

Regeneron Study Site, Jacksonville

32808

Regeneron Study Site, Orlando

33165

Regeneron Study Site, Miami

33756

Regeneron Study Site, Clearwater

34761

Regeneron Study Site, Ocoee

43235

Regeneron Study Site, Columbus

45224

Regeneron Study Site, Cincinnati

48723

Regeneron Study Site, Caro

60607

Regeneron Study Site, Chicago

60611

Regeneron Study Site, Chicago

72858

Regeneron Study Site, San Antonio

77004

Regeneron Study Site, Houston

77058

Regeneron Study Site, Houston

77401

Regeneron Study Site, Bellaire

85053

Regeneron Study Site, Phoenix

85306

Regeneron Study Site, Glendale

85308

Regeneron Study Site, Glendale

85412

Regeneron Study Site, Tucson

92805

Regeneron Study Site, Anaheim

60-702

Regeneron Study Site, Poznan

50-381

Regeneron Study Site, Wroclaw

01-192

Regeneron Study Site, Warsaw

80-382

Regeneron Study Site, Gdansk

81-537

Regeneron Study Site, Gdynia

42-202

Regeneron Study Site, Częstochowa

40-040

Regeneron Study Site, Katowice

90-127

Regeneron Study Site, Lodz

91-211

Regeneron Study Site, Lodz

WC1X8QD

Regeneron Study Site, London

PR7 7NA

Regeneron Study Site, Chorley

NN172UR

Regeneron Study Site, Corby

B15 2SQ

Regeneron Study Site, Edgbaston

G20 0SP

Regeneron Study Site, Glasgow

TS19 8PE

Regeneron Study Site, Hardwick

NE46 1QJ

Regeneron Study Site, Hexham

CV81JD

Regeneron Study Site, Kenilworth

DA146LT

Regulatory Study Site, London

RG401XS

Regeneron Study Site, London

RM13PJ

Regeneron Study Site, London

M15 6SX

Regeneron Study Site, Manchester

HA62RN

Regeneron Study Site, Northwood

PE73JL

Regeneron Study Site, Peterborough

RG2 0TG

Regeneron Study Site, Reading

BD183SL

Regeneron Study Site, Shipley

L22 0LG

Regeneron Study Site, Waterloo

All Listed Sponsors
collaborator

Teva Pharmaceutical Industries, Ltd.

INDUSTRY

lead

Regeneron Pharmaceuticals

INDUSTRY

NCT03691974 - Study to Evaluate the Effects of Fasinumab on Peripheral Nerve Function in Patients With Pain Due to Osteoarthritis of the Hip or Knee | Biotech Hunter | Biotech Hunter